Skip to main content
. 2019 Aug 29;20(17):4233. doi: 10.3390/ijms20174233
NBM normal bone marrow
FceRII Fc-epsilon receptor II
IL-2RA interleukin-2 receptor alpha chain
DPPIV dipeptidyl peptidase IV
IAP integrin associated protein
NCAM neural cell adhesion molecule
G-CSFR granulocyte colony-stimulating factor receptor
PROM1 prominin-1
PD-L1 programmed cell death-ligand 1
CLL-1 C-type lectin-like molecule-1
IL-1RAP interleukin-1 receptor accessory protein
n.c. not yet clustered
LSC leukemic stem cells
AML acute myeloid leukemia
CT chemotherapy
HSCT hematopoietic stem cell transplantation
AML acute myeloid leukemia
NCT national clinical trial identifier
BiTE bispecific T cell engagers
TriKE tri-specific killer engager
DART dual affinity retargeting antibody
CAR chimeric antigen receptor
NK natural killer cell
AML acute myeloid leukemia
MDS myelodysplastic syndrome
R/R refractory/resistant
USA United States of America
HSCT hematopoietic stem cell transplantation
DCN dendritic cell neoplasm
NK killer cells
RAEB refractory anemia with excess of blasts
NKG2D natural killer group 2D antigen